tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Drug License Suspension in Andhra Pradesh

Story Highlights
MedPlus Subsidiary Faces Drug License Suspension in Andhra Pradesh

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has shared an update.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for one of its stores in Andhra Pradesh. The suspension, issued by the Drug Control Administration of Vizianagaram District, is for a duration of seven days and is expected to result in a potential revenue loss of approximately Rs 0.91 lacs. This development highlights a regulatory challenge for the company, potentially impacting its operations and financial performance in the region.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on retail pharmacy services. The company is known for its extensive network of pharmacy stores across India, providing a wide range of pharmaceutical products and health-related services.

Average Trading Volume: 21,376

Technical Sentiment Signal: Hold

Current Market Cap: 89.78B INR

Learn more about MEDPLUS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1